🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To test the preliminary efficacy of 16.0 mg of Prazosin daily versus placeb...
Status
Completed
Location
Yale University School of Medicine: Yale Stress Center
Start Date
2009-09
Trial ID
NCT00585780
Treatments Being Tested
This study was recommended by NICE, as part of its 2006 guidance for the tr...
Status
Unknown
Location
NHS Ayrshire
Start Date
2009-05
Trial ID
NCT02369081
Treatments Being Tested
The study is an open-label, randomized,2-period, single dose, crossover stu...
Status
Completed
Location
Eurofins Optimed
Start Date
2024-04-23
Trial ID
NCT06147622
Treatments Being Tested
After a traumatic event such as an accident or an assault, victims may expe...
Status
Completed
Location
Groupement Hospitalier Edouard Herriot - Emergency Psychiatry Department
Start Date
2017-04-21
Trial ID
NCT03045016
Treatments Being Tested
Clinical trials have yet to test the adequacy of HTN control in African Ame...
Status
Completed
Location
Creighton Community Health Center
Start Date
2005-08
Trial ID
NCT00661895
* Rationale: The optimal preoperative medical management for patients with ...
Status
Completed
Location
Department of Endocrinology, University Medical Center Groningen
Start Date
2011-12
Trial ID
NCT01379898
Treatments Being Tested
A Trial to Assess the Effects of Prazosin or Propranolol on Blood Pressure ...
Status
Terminated
Location
For additional information regarding sites (California, Texas, New Jersey, Minnesota)
Start Date
2022-09-07
Trial ID
NCT05189977
Treatments Being Tested
This is a randomized, double-blind, placebo-controlled study of SNC-102 in ...
Status
Withdrawn
Location
Multiple Locations
Start Date
2016-06
Trial ID
NCT02384369
Treatments Being Tested
To test bioequivalence of Doxazosin 4 Mg Orally-disintegrating Tablet with ...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2011-07
Trial ID
NCT01389609
For patients recovering from acute illness, the ability to stand, walk, cli...
Status
Completed
Location
VA Portland Health Care System, Portland, OR
Start Date
2011-10
Trial ID
NCT01030874
Treatments Being Tested